Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of TechTarget, Inc. (“TechTarget” or the “Company”) (NASDAQ:TTGT).

TechTarget Unable to File its Annual Report on Form 10-K

In a March 31, 2025 “Notification of Late Filing,” TechTarget reported that it was unable to timely file its Annual Report on Form 10-K and “. . . is taking the extension period to further evaluate technical accounting matters arising while preparing its financial statements for the fiscal year ended December 31, 2024 . . . includ[ing] undertaking a technical assessment of the goodwill of the Industry Dive business, which was acquired in 2022.”

TechTarget also reported that it “. . . expects to record a pre-tax non-cash goodwill impairment charge related to the business in the range of approximately $70m to $110m in the year ended December 31, 2024.”

Following this news, TechTarget’s stock price fell from $14.81 per share on March 31, 2025 to $12.76 per share at the market’s close on April 1, 2025.

TechTarget Receives Nasdaq Notification Letter & Reports Certain Financial Statements Should No Longer Be Relied Upon Due to Material Errors 

On April 18, 2025, TechTarget reported that “[o]n April 17, 2025, the Company received a notification letter . . . from the Listing Qualifications Department of [Nasdaq] . . . stating that, because the Company failed to timely file its 2024 Form 10-K with the [SEC], the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) . . ., which requires Nasdaq-listed companies to timely file all required periodic financial reports with the SEC.”

Moreover, the Company reported that “[d]uring the preparation of the Company’s financial statements for the fiscal year ended December 31, 2024, the Company’s management identified certain material errors in the Affected Financial Statements relating to certain technical accounting matters associated with goodwill impairment, changes in contingent consideration, and amortization of intangibles, including related tax impacts thereof. The Company also identified, and will correct in the restatements, other out-of-period and uncorrected misstatements.”

TechTarget also reported that “[a]ny previously issued or filed reports, earnings releases, and investor presentations or other communications including or describing the Affected Financial Statements and related financial information covering the Non-Reliance Periods should no longer be relied upon.”

Lastly, TechTarget reported that “[s]imilarly, the report of . . . PricewaterhouseCoopers LLP . . . accompanying the audited combined financial statements of the Informa Tech Digital Businesses of Informa PLC as of December 31, 2023 and 2022 and for the three years ended December 31, 2023, should no longer be relied upon.”

TechTarget Investors May Have Legal Claims 

TechTarget stock investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the securities investigation and receive a free, no-obligation evaluation of potential legal claims.

For direct inquiries, TechTarget shareholders should contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Canopy Growth Corporation (“Canopy Growth” or “Canopy”) (NASDAQ:CGC).

Securities Class Action Lawsuit Filed 

On April 4, 2025, a class action complaint alleging violations of the federal securities laws was filed against Canopy Growth in United States District Court, Eastern District of New York (Case No. 1:25-cv-01877), on behalf of investors who purchased or otherwise acquired Canopy Growth securities between May 30, 2024 and February 6, 2025, both dates inclusive (the “Class Period”).

The class action lawsuit is pursuing remedies against Canopy and certain of its top officials under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

Class Action Allegations 

According to the complaint, throughout the Class Period, the Canopy Growth Defendants allegedly made false and/or misleading statements and/or failed to disclose that 1) Canopy incurred significant costs producing Claybourne pre-rolled joints in connection with the Claybourne product launch in Canada; 2) these costs, along with indirect costs related to its Storz & Bickel vaporizer devices, were likely to have a significant negative impact on Canopy Growth’s gross margins and overall financial results; and 3) as a result, the Canopy Growth Defendants overstated the effectiveness of Canopy’s cost reduction measures and the health of its gross margins while downplaying related issues.

Canopy Growth Investors May Have Legal Claims 

Investors who acquired Canopy Growth securities during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or send us a message to contact an attorney to discuss the class action lawsuit and receive a free, no-obligation evaluation of potential legal claims.

Canopy Growth shareholders can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of TransMedics Group, Inc. (“TransMedics”) (NASDAQ:TMDX).

Securities Class Action Lawsuits Filed 

Class action complaints alleging violations of the federal securities laws have been filed against TransMedics in United States District Court, District of Massachusetts (Case No. 1:25-cv-10778).

The class action lawsuits were filed on behalf of investors who purchased or otherwise acquired TransMedics securities between February 28, 2023 and January 10, 2025 (the “Class Period”).

To review the allegations contained in one of the complaints, click TransMedics Securities Class Action Complaint.

TransMedics Investors May Have Legal Claims 

Investors who acquired TransMedics securities during the Class Period are encouraged to complete Kehoe Law Firm’s Stockholder Information Request form or send us a message to contact an attorney to discuss the class action lawsuit and receive a free, no-obligation evaluation of potential legal claims.

TransMedics shareholders can also contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected].

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]